Samuel Thompson, MD
Adult Reconstructive Orthopaedic Surgery · Columbia, MONPI 1164878237
Payments from drug & device makers
What this record shows
This record is dominated by education: $27,404 of the $29,802 with a category attached, or 92.0%. Smith+Nephew accounts for 67.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $10,523 and has fallen 98.8% since, to $124 in 2025.
Across 47 payments — averaging $634.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$20K
- Pylant Medical$7K
- Johnson & Johnson$815
- Stryker$778
- Medical Device Business Services, Inc.$653
- Zimmer Biomet$347
- plus $338 from 6 others
What the payments were for
- Travel & lodging$9753%
- Food & beverage$1,4235%
- Education$27,40492%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $20,138 |
| Pylant Medical | 5 | $6,732 |
| Johnson & Johnson | 5 | $815 |
| Stryker | 14 | $778 |
| Medical Device Business Services, Inc. | 4 | $653 |
| Zimmer Biomet | 3 | $347 |
| Encore Medical, LP | 3 | $135 |
| Heraeus Medical, LLC. | 2 | $101 |
| Novo Nordisk | 3 | $52 |
| Bone Support Inc. | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Hospira, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$664
- ROSA-Knee$265
- MAKO$264
- Persona$140
- Anterior Supine$125
- Legion Revision$115
- OR3O Dual Mobility$115
- REDAPT$115
How this compares
$29,802 in reported general payments places this provider in the 65th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.
See all adult reconstructive orthopaedic surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 109 | $3,743 |
| Oxycodone Hcl | 109 | $821 |
| Tramadol Hcl | 163 | $702 |
| Ondansetron Hcl | 78 | $439 |
| Pantoprazole Sodium | 82 | $389 |
| Cefadroxil | 55 | $385 |
| Meloxicam | 37 | $84 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Columbia
- Thomas AletoColumbia$669K
- Ajay AggarwalColumbia$78K
- James KeeneyColumbia$22K
- Alan AnzColumbia$9K
- Elie GhanemColumbia$8K
- Jeffrey MillesColumbia$5K
- David HockmanColumbia$585
- Benjamin HoltColumbia$104
- Peter BuchertColumbia$46
- Robert BarrackSaint Louis$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.